ARCHIVES

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

This article is from The Cancer Letter archive.

Vol. 15 No. 04 | January 27, 1989

Download PDF Visit The Full Archive

Related Articles

Modality Combo Decreases Prostate Cancer Recurrence

August 27, 2004

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

May 16, 2008

Drug Approved in Europe For Pediatric Cancer Patients

April 24, 2009

ACS Encourages Research Proposals Psychosocial Aspects Of Cancer

March 26, 1982

Amgen Says It Can Demonstrate Safety of Existing Hg Target.

March 16, 2007

NIH Limits Salaries On Grants, Contracts ACS Clinical Awards Available For 1995

February 25, 1994